Hypertension Journal

Register      Login

VOLUME 2 , ISSUE 2 ( April-June, 2016 ) > List of Articles


Evaluation of Sympathetic Activity in Hypertension

Poghni A Peri-Okonny, Wanpen Vongpatanasin

Keywords : Hypertension,Microneurography,Muscle sympathetic nerve activity,Norepinephrine spillover,Renal denervation,Sympathetic nerve activity

Citation Information : Peri-Okonny PA, Vongpatanasin W. Evaluation of Sympathetic Activity in Hypertension. Hypertens J 2016; 2 (2):60-64.

DOI: 10.5005/jp-journals-10043-0033

Published Online: 01-06-2017

Copyright Statement:  Copyright © 2016; The Author(s).


How to cite this article

Peri-Okonny PA, Vongpatanasin W. Evaluation of Sympathetic Activity in Hypertension. Hypertens J 2016;2(2):60-64.

PDF Share
  1. The sympathetic nervous system alterations in human hypertension. Circ Res 2015 Mar 13;116(6):976-990.
  2. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertens Res 2012 Jan;35(1):4-16.
  3. Microneurography: how the technique developed and its role in the investigation of the sympathetic nervous system. J Appl Physiol 2004 Apr;96(4):1262-1269.
  4. Methods and considerations for the analysis and standardization of assessing muscle sympathetic nerve activity in humans. Auton Neurosci 2015 Dec;193:12-21.
  5. How to assess sympathetic activity in humans. J Hypertens 1999 Jun;17(6):719-734.
  6. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci 1997 Mar;92(3):285-289.
  7. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol 1992;453:45-58.
  8. Sympathetic nervous system and hypertension. Hypertension 2013 Mar;61(3):556-560.
  9. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986 Apr;73(4):615-621.
  10. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 1990 Oct;70(4):963-985.
  11. Mechanism of the blood pressure — raising effect of cocaine in humans. Circulation 2002 Mar 5;105(9):1054-1059.
  12. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in peri-menopausal women. Hypertension 1997 Dec;30(6):1538-1543.
  13. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997 Nov;96(10):3423-3429.
  14. Sympathetic neuroimaging. Handb Clin Neurol 2013;117:365-370.
  15. Pharmacological interference with 123i-metaiodobenzyl-guanidine: a limitation to developing cardiac innervation imaging in clinical practice? Eur Rev Med Pharmacol Sci 2013 May;17(10):1326-1333.
  16. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ Res 2014 Mar 14;114(6):1004-1021.
  17. Time and frequency domain assessment of heart rate variability: a theoretical and clinical appreciation. Clin Auton Res 1993 Apr;3(2):145-158.
  18. Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomicoutflowsbybaroreflexes. Exp Physiol 2011 Dec;96(12):1255-1261.
  19. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation 1999 Aug 3;100(5):497-502.
  20. Sympathetic restraint of respiratory sinus arrhythmia: Implications for vagal-cardiac tone assessment in humans. Am J Physiol Heart Circ Physiol 2001 Jun;280(6):H2804-H2814.
  21. Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly. J Hypertens 2000 May;18(5):587-593.
  22. Increased cardiac sympathetic drive in renovascular hypertension. J Hypertens 2002 Jun;20(6):1181-1187.
  23. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 1991 Jun;17(6 Pt 2):1057-1062.
  24. Reversible sympathetic overactivity in hypertensive patients with primary aldo-steronism. J Clin Endocrinol Metab 2010 Oct;95(10):4756-4761.
  25. Increased sympathetic nerve activity in renovascular hypertension. Circulation 1999 May 18;99(19):2537-2542.
  26. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992 Dec 31;327(27):1912-1918.
  27. Sympathetic nerve activity is inappropriately increased in chronic renal disease. J Am Soc Nephrol 2003 Dec;14(12):3239-3244.
  28. Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 2011 Apr;57(4):846-851.
  29. Spike rate of multi-unit muscle sympathetic nerve fibers after catheter-based renal nerve ablation. J Am Soc Hypertens 2015 Oct;9(10):794-801.
  30. The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients. Int J Cardiol 2014 Sep;176(1):8-12.
  31. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension. Int J Cardiol 2016 Jan 1;202:609-614.
  32. Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation 2003 Dec 23;108(25):3097-3101.
  33. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 2004 Dec;44(6):847-852.
  34. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 1998 Mar 17;97(10):943-945.
  35. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000 May 11;342(19):1378-1384.
  36. Single-unit muscle sympathetic nerve activity reflects sleep apnea severity, especially in severe obstructive sleep apnea patients. Front Physiol 2016 Mar 2;7:66.
  37. Effects of 12 months continuous positive airway pressure on sympathetic activity related brainstem function and structure in obstructive sleep apnea. Front Neurosci 2016 Mar 10;10:90.
  38. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 2011 Nov;58(5):811-817.
  39. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003 Oct 8;290(14):1906-1914.
  40. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003 Aug 5;108(5):560-565.
  41. Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension. Circulation 2007 Apr 17;115(15):1999-2005.
  42. Increased muscle sympathetic nerve activity predicts mortality in heart failure patients. Int J Cardiol 2009 Jul 10;135(3):302-307.
  43. Increased sympathetic nerve activity in copd is associated with morbidity and mortality. Lung 2014 Apr;192(2):235-241.
  44. Sympathetic hyperactivity and clinical outcome in chronic kidney disease patients during standard treatment. J Nephrol 2009 Mar-Apr;22(2):208-215.
  45. Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology 2001 Sep 11;57(5):833-838.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.